HAMNO is a protein interaction inhibitor of replication protein A (RPA).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 95 | |
10 mg | In stock | $ 161 | |
20 mg | In stock | $ 270 | |
50 mg | In stock | $ 438 | |
100 mg | In stock | $ 687 |
Description | HAMNO is a protein interaction inhibitor of replication protein A (RPA). |
Targets&IC50 | RPA: |
In vitro | HAMNO inhibits colony formation in both HNSCC cell lines. The combination of HAMNO with etoposide markedly inhibits colony formation to a greater degree than HAMNO alone. In UMSCC38 cells, HAMNO dose-dependently increased the occurs of pan-nuclear γ-H2AX staining. UMSCC38 and UMSCC11B cells have prominent γ-H2AX staining, particularly after incubation with HAMNO (20 μM). In UMSCC38 and OKF4 cells, HAMNO increased γ-H2AX staining, with the greatest increase in signal occurring in S-phase. |
In vivo | In mice, HAMNO inhibits the progression of UMSCC11B tumors. After treatment with etoposide (20 μM, 2 h), Ser33 of RPA32 (an ATR substrate) is highly phosphorylated, which is reduced with the addition of 2 μM HAMNO and is nearly absent at higher concentrations, demonstrating HAMNO can inhibit RPA32 phosphorylation by ATR. |
Synonyms | NSC111847 |
CAS No. | 138736-73-9 |
Chemical Formula | C17H13NO2 |
Molecular Weight | 263.296 |
Solubility | DMSO: 155 mg/mL |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom